Health-care companies slipped amid doubts about the outlook for growth.
Lawyers for biopharmaceutical company Sorrento Therapeutics disputed allegations that they committed bankruptcy fraud, saying that a bank account and mailbox created in Texas justified a chapter 11 filing in the state days later.
Novo Nordisk shares ticked up as traders continued to chase gains in obesity-drug makers.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
02-26-24 1732ET
